Morgan Stanley’s CAMP4 Therapeutics Corporation Common Stock CAMP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.45K Sell
1,687
-7,285
-81% -$10.6K ﹤0.01% 7182
2025
Q1
$35.9K Sell
8,972
-5,289
-37% -$21.2K ﹤0.01% 6378
2024
Q4
$74.4K Buy
+14,261
New +$74.4K ﹤0.01% 6161